Approval · Notice of Compliance 16516 · 2015
ZEVALIN: Notice of Compliance 16516
Issued January 13, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16516
- Date
- January 13, 2015
- Company
- Spectrum Pharmaceuticals Inc
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Therapeutic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVALIN | Not yet assigned | — |
Medicinal ingredients
- IBRITUMOMAB TIUXETAN 1.6 MG per ML